Skip to main content
CDC Website

Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed)

The purpose of this notice of funding opportunity (NOFO) is to support the evaluation of early-stage diagnostics and novel diagnostic strategies for Tuberculosis (TB) in the context of existing clinical algorithms in TB endemic countries. Evaluation studies should: 1) perform proof-of principle studies of novel diagnostic tests and strategies for TB, including among people living with HIV (PLWH) and 2) provide feedback to diagnostic developers and policy makers on the performance of the technologies and most effective strategies for use of the diagnostic technologies in an endemic setting.

Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Other Health-Related
TB
Support Types:
Cooperative Agreements
Locations:
International
Maximum Amount:
$3,500,000
Fund ID:
RFA-AI-24-010
Application Due Date:
Subjects:
Data Analysis
Epidemiological Research
Health Care Planning
Health Care Programs/Services
HIV
Research
TB
TB Prevention
Audiences:
At Risk Persons
Community Based Organizations
Health Professionals
Health Services Organizations
Persons with HIV/AIDS
Persons with TB
Researchers
Application Contact
Vandhana
Khurana
Financial/Grants Management Contact- NIAID
2406692966
vandhana.khurana@nih.gov
Technical Contact
NIH Grants Information
grantsinfo@nih.gov